Latest Headlines

  1. Baylor Genetics And Baylor College Of Medicine Announce New Lab Agreement With Shared Commitment To Innovation And Rapid Implementation To Get Critical Testing To Patients 8/5/2024

    Baylor Genetics, a joint venture clinical diagnostic laboratory at the forefront of genetic testing, and the Department of Molecular and Human Genetics at Baylor College of Medicine have entered a lab agreement focusing on innovation and high-risk projects that have potentially great clinical impact.

  2. Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide 8/5/2024

    Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the expansion of blood volume analysis (BVA) in three new facilities.

  3. Seegene Showcased Its Multiplex Technology At ADLM 2024 8/5/2024

    Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, showcased its key products and systems at the Association for Diagnostics & Laboratory Medicine 2024 (ADLM 2024) under the exhibition theme "One Sample, Many Answers."

  4. Tria Federal Launches Technology Innovation Group, Tria Labs 8/1/2024

    Tria Federal, the premier middle-market technology and advisory services provider delivering digital transformation solutions to Health, Civilian, and Defense agencies across the federal sector, today announced the launch of its new technology innovation group, Tria Labs.

  5. Indica Labs Announces Launch Of AI-Powered Macrodissection Suite To Advance Molecular Pathology Workflows 8/1/2024

    Indica Labs, the leading provider of AI-powered digital pathology solutions, proudly announces the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes sli­­de macrodissection and molecular pathology workflows.

  6. Dxcover Multi-Omic Cancer Early Detection Platform Recognized By Academy Of Diagnostics & Laboratory Medicine For Scientific Excellence 7/31/2024

    Dxcover Limited, a clinical-stage diagnostics company pioneering its multi-omic spectral analysis (MOSA-Dx) for early detection of solid tumor cancers, will present its latest clinical evidence as a Distinguished Abstract at the Academy of Diagnostics & Laboratory Medicine Annual Meeting in Chicago July 28 – August 1, 2024.

  7. Pillar Biosciences' FDA Approved Solid Tumor NGS Kit oncoReveal™ CDx Launched At Molecular Pathology Laboratory Network, Inc. 7/30/2024

    Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced that Molecular Pathology Laboratory Network, Inc., (MPLN) is now the first national molecular reference laboratory to verify and launch oncoReveal™ CDx.

  8. Sapio Sciences And Zifo Announce Strategic Partnership 7/30/2024

    Sapio Sciences, the science-aware lab informatics platform, and Zifo, the leading scientific informatics services company, today announced a strategic partnership to bring best-in-class laboratory information management solutions to customers across the biotech, clinical diagnostics, and pharmaceutical industries.

  9. Agilent Acquires Sigsense, Creator Of AI-Enabled Lab Operations Technology 7/29/2024

    Agilent Technologies Inc. today announced it has acquired Sigsense Technologies, a San Francisco, California-based startup that uses artificial intelligence and power monitoring to help optimize lab operations. Financial terms of the acquisition were not disclosed.

  10. In Response To FDA LDT Final Rule, LISA Launches Crowdfunding Initiative For Clinical Laboratories 7/29/2024

    The Laboratory Integration Strategic Association (LISA) proudly announces its official launch, ushering in a new era of collaboration and innovation in clinical testing.